Global Prosthetic Heart Valves Market 2022-2028

Description

List of Tables

Global Prosthetic Heart Valves Market Size, Share & Trends Analysis Report by Type (Mechanical Heart Valves and Biological/Tissue Heart Valves), and by End-Users (Hospitals and Ambulatory Centers) Forecast Period (2022-2028)

The global prosthetic heart valvemarket is anticipated to grow at a substantial CAGR of 9% during the forecast period. The various launches by players in the prosthetic heart valve market are the key factor contributing to the growth of the market over the forecast period. For instance, in November 2020, Abbott, the global healthcare company, launched its clip delivery system, a minimally invasive heart valve repair device to treat mitral regurgitation in India. This product puts new technology into the hands of physicians by giving them a life-saving treatment option that may be used for people suffering from mitral regurgitation due to a heart defect or as a result of heart failure.

The global prosthetic heart valvemarket is segmented based on the type and end-users Based on the type, the market is bifurcated into mechanical heart valves and biological/tissue heart valves. Based on the end-users, the market is augmented into the hospital and ambulatory centers. Above mentioned segments can be customized as per the requirements.The biological/tissue heart valves are expected to be the fastest-growing segment over the forecast period. The main advantage of biological valves is that there's less risk of clots forming, so lifelong anticoagulant treatment isn't usually necessary. But biological valves tend to wear out a bit faster than mechanical valves and may eventually need to be replaced after many years.

Geographically the global prosthetic heart valvemarket is segmented into North America, Europe, Asia Pacific, and the Rest of the World. Asia-Pacific is expected to be the fastest-growing region during the forecast period. The market is mainly driven by the increasing prevalence of chronic diseases, such as CVD, coupled with government initiatives toward awareness of heart valve diseases. China, Japan, and India contribute significantly to the growth of the market due to increasing healthcare spending and growing medical tourism in these countries.

The major companies serving the global prosthetic heart valvesmarket include Cardiosolutions, Inc. (Ingenovis Health), Colibri Heart Valve LLC, enVVeno Medical Corp., HLT, Inc., and others.The market players are considerably contributing to the market growth by the adoption of various strategies including mergers andacquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in September 2019, Medtronic launched the Evolut PRO+ transcatheter aortic valve replacement (TAVR) System in the US, following the receipt of approval from the US Food and Drug Administration (FDA).The Evolut PRO+ TAVR System comes with four-valve sizes and an external pericardial tissue wrap to provide sealing for the highest indicated treatment range, as well as the lowest delivery profile on the market. Moreover, the device is indicated to treat patients with symptomatic severe aortic stenosis.

Research Methodology

The market study of the global prosthetic heart valvemarket is incorporated by extensive primary and secondary research conducted by the research team at OMR.Secondary research has been conducted to refine the available data to break down the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

Financial reports of companies involved in the market.
Whitepapers, research papers, and news blogs.
Company websites and their product catalog.

The report provides an in-depth analysis of the market size, andintended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Global Prosthetic Heart Valves Market Research and Analysis by Type.

2. Global Prosthetic Heart Valves Market Research and Analysis by End-Users.

The Report Covers

Comprehensive research methodology of the global prosthetic heart valvemarket.
This report also includes a detailed and extensive market overview with key analyst insights.
An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the global prosthetic heart valves market.
Insights about market determinants that are stimulating the global prosthetic heart valvesmarket.
Detailed and extensive market segments with the regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.

Product Code: OMR2017195

Category- Medical Devices

1. Report Summary

Current Industry Analysis and Growth Potential Outlook
Impact of COVID-19 on the Global Prosthetic Heart Valves Market
Recovery Scenario of Global Prosthetic Heart Valves Market
1.1. Research Methods and Tools
1.2. Market Breakdown
- 1.2.1. By Segments
- 1.2.2. ByRegion

2. Market Overview and Insights

2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
- 2.2.1. Key Findings
- 2.2.2. Recommendations
- 2.2.3. Conclusion

3. Competitive Landscape

3.1. Abbott Laboratories Inc.
- 3.1.1. Overview
- 3.1.2. Financial Analysis
- 3.1.3. SWOT Analysis
- 3.1.4. Recent Developments
3.2. Boston Scientific Corp.
- 3.2.1. Overview
- 3.2.2. Financial Analysis
- 3.2.3. SWOT Analysis
- 3.2.4. Recent Developments
3.3. AbboEdwards Lifesciences Corp.
- 3.3.1. Overview
- 3.3.2. Financial Analysis
- 3.3.3. SWOT Analysis
- 3.3.4. Recent Developments
3.4. CryoLife, Inc.
- 3.4.1. Overview
- 3.4.2. Financial Analysis
- 3.4.3. SWOT Analysis
- 3.4.4. Recent Developments
3.5. LivaNova PLC
- 3.5.1. Overview
- 3.5.2. Financial Analysis
- 3.5.3. SWOT Analysis
- 3.5.4. Recent Developments
3.6. Key Strategy Analysis
3.7. Impact of Covid-19 on Key Players

4. Market Segmentation

4.1. Global Prosthetic Heart Valves Market by Type
- 4.1.1. Mechanical Heart Valves
- 4.1.2. Biological/Tissue Heart Valves
4.2. Global Prosthetic Heart Valves Market by End-User
- 4.2.1. Hospitals
- 4.2.2. Ambulatory Centers

5. Regional Analysis

5.1. North America
- 5.1.1. United States
- 5.1.2. Canada
5.2. Europe
- 5.2.1. UK
- 5.2.2. Germany
- 5.2.3. Italy
- 5.2.4. Spain
- 5.2.5. France
- 5.2.6. Rest of Europe
5.3. Asia-Pacific
- 5.3.1. China
- 5.3.2. India
- 5.3.3. Japan
- 5.3.4. South Korea
- 5.3.5. Rest of Asia-Pacific
5.4. Rest of the World

6. Company Profiles

6.1. BraileBiomedica
6.2. Cardiosolutions, Inc. (Ingenovis Health)
6.3. Colibri Heart Valve LLC
6.4. enVVeno Medical Corp.
6.5. HLT, Inc.
6.6. JenaValve Technology, Inc.
6.7. Lepu Medical Technology Co., Ltd.
6.8. Medtentia International Ltd Oy
6.9. Medtronic PLC
6.10. Micro Interventional Devices, Inc.
6.11. Novostia SA
6.12. The Charles Stark Draper Laboratory, Inc.
6.13. TTK Healthcare Ltd.